Myricetin also acts as a potent inhibitor of human flap endonuclease 1 (hFEN1) protein (IC50 690 nM), based on inhibitory mechanisms, molecular docking, and cancer cell-based assays [128]. This evidence concerns the gene FEN1 and cancer.